Empagliflozin/linagliptin/metformin - Boehringer Ingelheim/Eli Lilly and Company
At a glance
- Drug Originator Boehringer Ingelheim; Eli Lilly and Company
- Drug Class Alkynes; Amines; Antihyperglycaemics; Benzhydryl compounds; Biguanides; Cardiovascular therapies; Chlorinated hydrocarbons; Cyclic ethers; Eye disorder therapies; Glucosides; Heart failure therapies; Ketones; Piperidines; Purines; Quinazolines; Small molecules; Urologics
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 34
- NDAs 1
- International Patents 486
Table of Contents

Disclaimer